Shares of Invitae (NVTA +0.00%) were crashing 19.4% lower as of 12:13 p.m. ET on Thursday. The decline came on the heels of two developments. Invitae revealed in a regulatory filing on Wednesday that ...

As of the third quarter of 2023, Invitae had already tallied a net loss of more than $1.3 billion for the year, with cash burn of $311 million as of Sept. 30 and just under $265 million left in cash ...

It's been a sad week for Invitae Corporation (NYSE:NVTA), who've watched their investment drop 12% to US$23.82 in the week since the company reported its full-year result. The results look positive ...

Invitae Corporation (NYSE:NVTA), a US$1.26b small-cap, is a healthcare company operating in an industry, which has experienced tailwinds from issues such as higher demand driven by an aging population ...

Invitae (NYSE: NVTA) has grown revenue over time, but the genetic testing specialist has failed to turn that into profit. Instead, the company burned through more and more cash, prompting it to launch ...

Invitae is among the companies pioneering genomics. The company is building a platform that can use DNA to drive smarter healthcare decision-making throughout various life stages. However, the company ...

SAN FRANCISCO, March 16, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of W. Michael Korn, M.D., as its chief medical officer for ...

Invitae Corporation (NVTA) is a San Francisco based genetics testing and information company. The company grows primarily through acquisition, having spent over $2.5 billion on ten companies since ...

Invitae Corporation (NYSE:NVTA), backed by SoftBank Group (OTC:SFTBY) (OTC:SFTBF), is reportedly on the brink of filing for bankruptcy in the coming weeks. The San Francisco-based medical genetics ...

Invitae recently revealed that it is acquiring Jungla for approximately $50 million upon closing. These are the details behind the deal. Recently, medical genetics company Invitae entered into a ...

Invitae also recently launched a new service model that allows consumers to initiate and order health screening tests and receive genetic guidance through a telemedicine service. (Pixabay) Genetic ...